How do you explain MGUS to a patient?
Monoclonal gammopathy of undetermined significance (MGUS) is a condition in which an abnormal protein — known as monoclonal protein or M protein — is in your blood. This abnormal protein is formed within your bone marrow, the soft, blood-producing tissue that fills in the center of most of your bones.
How can I help someone with myeloma?
Offer a listening ear Sometimes, people with multiple myeloma just want to talk and express how they feel. Even though you may also feel scared, it’s important to provide a listening ear and offer encouragement. Being able to talk or cry freely about their diagnosis may help them feel better.
What is the nursing management of the patient with multiple myeloma?
Key goals for effective management include: pain assessment and control; educating patients on the need for adequate hydration; prompt recognition of the signs of spinal-cord compression and hypercalcaemia; management of fatigue; psychosocial support of the patient and family; and provision of relevant, high-quality.
How do you monitor MGUS?
People with MGUS need to be monitored with blood and urine testing every 6 to 12 months to determine if MGUS is progressing. For a small percentage of individuals, the condition develops into cancerous conditions, such as multiple myeloma or lymphoma.
What is high risk MGUS?
People who have high-risk MGUS have any of the following features: The M-protein level is more than 15 g/L. The type of M-protein is IgA or IgM. The free light chain ratio is abnormal.
How does myeloma affect your daily life?
Background. Deterioration in bone health is one of the presenting symptoms of Multiple Myeloma (MM), a cancer of plasma cells. As a consequence of this condition, patients suffer bone pain and bone damage and report cancer-related fatigue, resulting in deterioration in their quality of life.
How do you live with myeloma?
Adopting healthy behaviors such as not smoking, eating well, getting regular physical activity, and staying at a healthy weight might help, but no one knows for sure. However, we do know that these types of changes can have positive effects on your health that can extend beyond your risk of myeloma or other cancers.
What is the best diet for MGUS?
Fiber.
- Fruits like apples and pears.
- Dried fruits like figs and prunes.
- Whole grains.
- Oatmeal and other cereals.
- Nuts and beans.
- Vegetables like broccoli, carrots, celery, and artichokes.
Is exercise good for multiple myeloma?
Physical activity has been shown to improve quality of life in cancer patients with some evidence in multiple myeloma.
Which complication would the nurse expect to find in a patient diagnosed with multiple myeloma?
Multiple myeloma impacts many body systems. The CRAB features generally specify symptoms that lead to complications in multiple myeloma: Calcium elevation; Renal dysfunction; Anemia; Bone disease.
What are the complications of multiple myeloma?
Complications of multiple myeloma include:
- Frequent infections. Myeloma cells inhibit your body’s ability to fight infections.
- Bone problems. Multiple myeloma can also affect your bones, leading to bone pain, thinning bones and broken bones.
- Reduced kidney function.
- Low red blood cell count (anemia).
What is the risk of progression from MGUS to active myeloma?
The risk of a patient’s progression from MGUS to active myeloma is only 1% per year. A hematologist/oncologist (specializes in cancers of the blood) should monitor patients with MGUS. MGUS patients do not need to undergo treatment unless they choose to take part in a clinical trial. What Is Smoldering Multiple Myeloma?
What is the criteria for diagnosis of multiple myeloma?
Criteria for diagnosis — The diagnosis of MM requires the following: ● A bone marrow aspirate or biopsy showing that at least 10 percent of the cells are plasma cells or the presence of a plasma cell tumor (called a plasmacytoma), plus at least one of the following two features:
What is the standard of care for multiple myeloma (SMM)?
The standard of care for SMM is not to treat the patient but to “watch and wait.” There are clinical trials available to treat patients with SMM and “high-risk” SMM before their disease progresses. Consult a hematologist/oncologist to tell apart MGUS, SMM, and active myeloma.
What is the treatment for MGUS?
Monitoring can typically be done by your primary care doctor under the guidance of doctors at Memorial Sloan Kettering. As long as the levels of M protein do not rise, MGUS requires no treatment.